Citadel Advisors’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
114,300
-488,200
-81% -$4.48M ﹤0.01% 8132
2026
Q1
$5.6M Buy
602,500
+30,800
+5% +$303K ﹤0.01% 4163
2025
Q4
$4M Sell
571,700
-256,300
-31% -$1.61M ﹤0.01% 4658
2025
Q3
$4.73M Buy
828,000
+96,600
+13% +$516K ﹤0.01% 4455
2025
Q2
$3.5M Buy
731,400
+532,400
+268% +$3.06M ﹤0.01% 4709
2025
Q1
$1.73M Buy
199,000
+164,200
+472% +$1.72M ﹤0.01% 5820
2024
Q4
$422K Buy
34,800
+24,100
+225% +$337K ﹤0.01% 8933
2024
Q3
$180K Sell
10,700
-47,800
-82% -$787K ﹤0.01% 10308
2024
Q2
$914K Buy
58,500
+47,200
+418% +$656K ﹤0.01% 6772
2024
Q1
$178K Sell
11,300
-11,000
-49% -$184K ﹤0.01% 10508
2023
Q4
$448K Sell
22,300
-37,800
-63% -$640K ﹤0.01% 8342
2023
Q3
$1.11M Buy
60,100
+22,000
+58% +$479K ﹤0.01% 6341
2023
Q2
$829K Buy
38,100
+9,500
+33% +$172K ﹤0.01% 6855
2023
Q1
$530K Buy
28,600
+7,500
+36% +$141K ﹤0.01% 8181
2022
Q4
$321K Sell
21,100
-2,300
-10% -$32.8K ﹤0.01% 9161
2022
Q3
$327K Buy
23,400
+7,900
+51% +$159K ﹤0.01% 9378
2022
Q2
$373K Sell
15,500
-600
-4% -$16.1K ﹤0.01% 9300
2022
Q1
$497K Buy
16,100
+10,400
+182% +$374K ﹤0.01% 9414
2021
Q4
$259K Sell
5,700
-18,100
-76% -$774K ﹤0.01% 11262
2021
Q3
$1.03M Buy
23,800
+11,100
+87% +$483K ﹤0.01% 8072
2021
Q2
$585K Buy
12,700
+1,100
+9% +$50.8K ﹤0.01% 9692
2021
Q1
$516K Buy
+11,600
New +$486K ﹤0.01% 9604

Other funds holding NEOG

Citadel Advisors's NEOG Position: Q2 2026 in Review

Citadel Advisors reduced its Neogen (NEOG) stake by 91% in Q2 2026, selling an estimated $8.38M and leaving 85,829 shares worth $772K. The position accounts for ﹤0.01% of the portfolio, ranked #8838.

Citadel Advisors first reported a position in NEOG in Q2 2014 and has held it in 43 quarters since. The position peaked at $77.3M in Q3 2023. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Citadel Advisors held 85,829 shares of Neogen worth $772K as of Q2 2026.
  • Citadel Advisors sold 912,775 Neogen shares in Q2 2026, an estimated $8.38M.
  • Neogen made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8838 holding.
  • Citadel Advisors first reported a position in Neogen in Q2 2014 and has held it in 43 quarters since.
  • Citadel Advisors's Neogen position peaked at $77.3M in Q3 2023.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.